相关实验视频

Updated: Jan 9, 2026

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart

Published on: May 19, 2017

心脏病中的耐药性:从分子机制到临床影响

Yicheng Ling¹, Baixue Han¹, Tianxiang Gu¹

¹The First Hospital of China Medical University, Shenyang, China.

Frontiers in endocrinology

|December 5, 2025

概括

抵抗素是一种关键的炎症调解剂,通过受体信号传递和心脏功能障碍驱动心血管疾病. 了解它的作用对于开发心脏病的新疗法至关重要.

科学领域:

心血管生物学心血管生物学
内分泌学在内分泌学.
免疫学免疫学免疫学

背景情况:

抵抗素是一种富含氨酸的阿迪波金,具有特定物种的功能,主要是作为人类的炎症调解剂.
它是由像单细胞和巨细胞这样的免疫细胞分泌的,影响心脏代谢疾病.
它的作用超越了葡萄糖代谢,扩展到心血管病理生理学.

研究的目的:

审查抵抗素在心血管病理生理学中的多方面的作用.
为了阐明抵抗素的受体相互作用 (TLR4,CAP-1) 和下游信号通路 (NF-κB,MAPK).
将分子机制与心血管疾病的临床证据相结合.

主要方法:

文献综述综合了当前关于resistin心血管影响的证据.
对抗素与TLR4和CAP-1受体相互作用的分析.
评估抵抗素对内皮,血管和心肌功能的影响.
整合了临床数据对抗体水平和心血管结果.

主要成果:

抵抗素激活TLR4和CAP-1,导致促炎级联 (NF-κB,MAPK),导致内皮功能障碍和动脉动脉产生.
它直接损害心肌细胞功能,诱导缩,并通过JAK/STAT3和TGF-β促进心脏纤维化.
抵抗素调节神经激素通路,加剧高血压和不利的心脏重塑.
升高的抵抗素与不良心血管事件相关,特别是在心力衰竭和心脏代谢疾病中.

结论:

电阻素是通过多种分子机制对心血管疾病病原发生的重要贡献者.
它在心血管疾病中的预后价值需要进一步研究.
向抗原是一种潜在的治疗策略,尽管人类数据有限.

关键词:

动脉样硬化动脉样硬化心脏病:心脏病是一种心脏病.心脏衰竭是因为心脏衰竭.预测价值的预测价值是什么耐药性耐药性是一种抗药性.

更多相关视频

A Simple and Effective Method to Consistently Isolate Mouse Cardiomyocytes

A Simple and Effective Method to Consistently Isolate Mouse Cardiomyocytes

Published on: November 11, 2022

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

相关概念视频

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...